undefined
Skip to main content
Australia|en-AU

Add a bookmark to get started

Global Site
Africa
MoroccoEnglish
South AfricaEnglish
Asia Pacific
AustraliaEnglish
Hong Kong SAR ChinaEnglish简体中文
KoreaEnglish
New ZealandEnglish
SingaporeEnglish
ThailandEnglish
Europe
BelgiumEnglish
Czech RepublicEnglish
HungaryEnglish
IrelandEnglish
LuxembourgEnglish
NetherlandsEnglish
PolandEnglish
PortugalEnglish
RomaniaEnglish
Slovak RepublicEnglish
United KingdomEnglish
Middle East
BahrainEnglish
QatarEnglish
North America
Puerto RicoEnglish
United StatesEnglish
OtherForMigration
6 June 20242 minute read

Life Sciences Index 2024

Perceptions of innovation and growth by the world's largest biopharma and medtech companies

Welcome to the first edition of the Life Sciences Index, a study about perceptions of innovation and growth in the life sciences industry. The survey explores the current drivers of – and barriers to – innovation and growth by the world’s largest biopharma and medtech companies.

We surveyed 200 industry leaders from the world’s top biopharma and medtech companies and asked for their insights on the market environment for incentivising innovation and growth, including four specific themes: dealmaking, sustainability and ESG, intelligent technology and the future of care delivery.

The result is a comprehensive state of the market report, published every two years, that will track perceptions of innovation and growth over time.

Key highlights

The overall Life Sciences Index Score for 2024 is 5.3 out of 7. This means respondents view the global life sciences industry as somewhat attractive for incentivising innovation and growth.

Some key findings from the Index include:

  • Only 36% of respondents believe leveraging artificial intelligence and machine learning is a strategic priority.
  • 49% predict deal activity to increase over the next 12 months, while 43% think it will stay broadly the same.
  • Only 13% say that ESG is a strategic priority for their business.
  • 79% strongly agree that innovators will routinely offer holistic packages of patient and HCP support.
  • The top three markets for fostering innovation and growth are the US, EU and China.

Global Life Sciences Index Events 2024

Our global Life Sciences team has hosted exclusive roundtable events in the following locations, providing opportunities to discuss the findings of the Index with your peers.

  • Birmingham, United Kingdom
  • Dubai, UAE
  • Dublin, Ireland
  • Lisbon, Portugal
  • London, United Kingdom
  • Madrid, Spain
  • Milan, Italy
  • Warsaw, Poland
Life Sciences Index Global Events Map Infographic

Explore more